1,516
Views
9
CrossRef citations to date
0
Altmetric
Research Papers

Purification and immunogenicity of hemagglutinin from highly pathogenic avian influenza virus H5N1 expressed in Nicotiana benthamiana

, , , , , , , , , , & show all
Pages 306-313 | Accepted 19 Sep 2015, Published online: 31 Jan 2017

References

  • World Health Organization. Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO: 10 August 2012. http://www.who.int/influenza/human_animal_interface/EN_GIP_20120810CumulativeNumberH5N1cases.pdf, 2012
  • World Health Organization. Pandemic (H1N1) 2009 – update 103, 4 June 2010. http://www.who.int/csr/don/2010_06_04/en/index.html, 2010
  • Chen H, Smith GJD, Li KS, Wang J, Fan XH, Rayner JM, Vijaykrishna D, Zhang JX, Zhang LJ, Guo CT, et al. Establishment of multiple sublineages of H5N1 influenza virus in Asia: Implications for pandemic control. PNAS USA 2006; 103:2845-50; PMID:16473931; http://dx.doi.org/10.1073/pnas.0511120103
  • Balasubramaniam VRMT, Hassan SS, Omar AR, Mohamed M, Noor SM, Mohamed R, Othman I. Cellular transcripts regulated during infections with Highly Pathogenic H5N1 Avian Influenza virus in 3 host systems. Virology J 2011; 8:196; http://dx.doi.org/10.1186/1743-422X-8-196
  • Oveissi S, Omar AR, Yusoff K, Jahanshiri F, Hassan SS. DNA vaccine encoding avian influenza virus H5 and Esat-6 of Mycobacterium tuberculosis improved antibody responses against AIV in chickens. Comp Immunol Microbiol Infect Dis 2010; 33:491-503; PMID:19781778; http://dx.doi.org/10.1016/j.cimid.2009.08.004
  • Basaran P, Rodríguez-Cerezo E. Plant molecular farming: opportunities and challenges. Crit Rev Biotechnol 2008; 28:153-72; PMID:18937106; http://dx.doi.org/10.1080/07388550802046624
  • Tiwari S, Verma PC, Singh PK, Tuli R. Plants as bioreactors for the production of vaccine antigens. Biotechnol Adv 2009; 27:449-67; PMID:19356740; http://dx.doi.org/10.1016/j.biotechadv.2009.03.006
  • Twyman RM, Schillberg S, Fischer R. The Production of Vaccines and Therapeutic Antibodies in Plants. In: Molecular Farming in Plants: Recent Advances and Future Prospects. Wang, A. and Ma, S, eds. Springer Science+Business Media B.V., The Netherlands. Chapter 7. 2012; pp. 145-58
  • Xu J, Dolan MC, Medrano G, Cramer CL, Weathers PJ. Green factory: plants as bioproduction platforms for recombinant proteins. Biotechnol Adv 2012; 30:1171-84; PMID:21924345; http://dx.doi.org/10.1016/j.biotechadv.2011.08.020
  • Stoger E, Fischer R, Moloney M, Ma JK. (2014) Plant molecular pharming for the treatment of chronic and infectious diseases. Annu Rev Plant Biol 2014; 65:743-68; PMID:24579993; http://dx.doi.org/10.1146/annurev-arplant-050213-035850
  • Gomord V, Faye L. Posttranslational modification of therapeutic proteins in plants. Curr Opin Plant Biol 2004; 7:171-81; PMID:15003218; http://dx.doi.org/10.1016/j.pbi.2004.01.015
  • Rybicki EP. Plant-made vaccines for humans and animals. Plant Biotechnol J 2010; 8:620-37; PMID:20233333; http://dx.doi.org/10.1111/j.1467-7652.2010.00507.x
  • Yusibov V, Streatfield S, Kushnir N. Clinical development of plant-produced recombinant pharmaceuticals vaccines, antibodies and beyond. Human Vaccin 2011; 7:1-9; http://dx.doi.org/10.4161/hv.7.3.14207
  • Yusibov V, Kushnir N, Streatfield SJ. Advances and challenges in the development and production of effective plant-based influenza vaccines. Expert Rev Vaccin 2015; 14:519-35; http://dx.doi.org/10.1586/14760584.2015.989988
  • Sunil Kumar GB, Ganapathi TR, Srinivas L, Revathi CJ, Bapat VA. Expression of hepatitis B surface antigen in transgenic banana plants. Planta 2005a; 222:484-93; PMID:15918027; http://dx.doi.org/10.1007/s00425-005-1556-y
  • Sunil Kumar GB, Ganapathi TR, Srinivas L, Revathi CJ, Bapat VA. Secretion of hepatitis B surface antigen in transformed tobacco cell suspension cultures. Biotechnol Lett 2005b; 27:927-32; PMID:16091888; http://dx.doi.org/10.1007/s10529-005-7185-5
  • Arlen PA, Singleton M, Adamovicz JJ, Ding Y, Davoodi-Semiromi A, Daniell H. Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts. Inf Immun 2008; 76:3640-50; http://dx.doi.org/10.1128/IAI.00050-08
  • Chichester JA, Musiychuk K, Farrance CE, Mett V, Lyons J, Mett V, Yusibov V. A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague. Vaccine 2009; 27:3471-4; PMID:19200825; http://dx.doi.org/10.1016/j.vaccine.2009.01.050
  • Chichester JA, Musiychuk K, de la Rosa P, Horsey A, Stevenson N, Ugulava N, Rabindran S, Palmer GA, Mett V, Yusibov V. Immunogenicity of a subunit vaccine against Bacillus anthracis. Vaccine 2007; 25:3111-4; PMID:17280756; http://dx.doi.org/10.1016/j.vaccine.2007.01.068
  • Chichester JA, Manceva SD, Rhee A, Coffin MV, Musiychuk K, Mett V, Shamloul M, Norikane J, Streatfield SJ, Yusibov V. A plant-produced protective antigen vaccine confers protection in rabbits against a lethal aerosolized challenge with Bacillus anthracis Ames spores. Hum Vaccin Immunother 2013; 9:544-52; PMID:23324615; http://dx.doi.org/10.4161/hv.23233
  • Farrance CE, Rhee A, Jones RM, Musiychuk K, Shamloul M, Sharma S, Mett V, Chichester JA, Streatfield SJ, Roeffen W. A plant-produced Pfs230 vaccine candidate blocks transmission of Plasmodium falciparum. Clin Vaccine Immunol 2011; 18:1351-7; PMID:21715576; http://dx.doi.org/10.1128/CVI.05105-11
  • Jones RM, Chichester JA, Mett V, Jaje J, Tottey S, Manceva S, Casta LJ, Gibbs SK, Musiychuk K, Shamloul M. A plant-produced Pfs25 VLP malaria vaccine candidate induces persistent transmission blocking antibodies against Plasmodium falciparum in immunized mice. PLoS One 2013; 8:e79538; PMID:24260245; http://dx.doi.org/10.1371/journal.pone.0079538
  • Jones RM, Chichester JA, Manceva S, Gibbs SK, Musiychuk K, Shamloul M, Norikane J, Streatfield SJ, van de Vegte-Bolmer M, Roeffen W. A novel plant-produced Pfs25 fusion subunit vaccine induces long-lasting transmission blocking antibody responses. Hum Vaccin Immunother 2015; 11:124-32; PMID:25483525; http://dx.doi.org/10.4161/hv.34366
  • Landry N, Ward BJ, Trépanier S, Montomoli E, Dargis M, Lapini G, Vézina LP. Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza. PLoS One 2010; 5:e15559; PMID:21203523; http://dx.doi.org/10.1371/journal.pone.0015559
  • Chichester JA, Jones RM, Green BJ, Stow M, Miao F, Moonsammy G, Streatfield SJ Yusibov V. Safety and immunogenicity of a plant-produced recombinant hemagglutinin-based influenza vaccine (HAI-05) derived from A/Indonesia/05/2005 (H5N1) influenza virus: a phase 1 randomized, double-blind, placebo-controlled, dose-escalation study in healthy adults. Viruses 2012; 4:3227-44; PMID:23202523; http://dx.doi.org/10.3390/v4113227
  • Cummings JF, Guerrero ML, Moon JE, Waterman P, Nielsen RK, Jefferson S, Gross FL, Hancock K, Katz JM, Yusibov V and Fraunhofer USA Center for Molecular Biotechnology Study Group. Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: a Phase 1 dose-escalation study in healthy adults. Vaccine 2014; 32:2251-9; PMID:24126211; http://dx.doi.org/10.1016/j.vaccine.2013.10.017
  • Landry N, Pillet S, Favre D, Poulin JF, Trépanier S, Yassine-Diab B, Ward BJ. Influenza virus-like particle vaccines made in Nicotiana benthamiana elicit durable, poly-functional and cross-reactive T cell responses to influenza HA antigens. Clin Immunol 2014; 154:164-77; PMID:25128897; http://dx.doi.org/10.1016/j.clim.2014.08.003
  • Ward BJ, Landry N, Trépanier S, Mercier G, Dargis, M, Couture M, D'Aoust MA, Vézina LP. Human antibody response to N-glycans present on plant-made influenza virus-like particle (VLP) vaccines. Vaccine 2014; 32:6098-106; PMID:25240757; http://dx.doi.org/10.1016/j.vaccine.2014.08.079
  • The Poultry Site. USDA Issues License For Plant Cell Produced Newcastle Disease Vaccine For Chickens. 2 February 2006. http://www.thepoultrysite.com/poultrynews/8949/usda-issues-license-for-plant-cell-produced-newcastle-disease-vaccine-for-chickens/, 2006
  • Ward WW, Swiatek G. Protein purification. Curr Anal Chem 2009; 5:1-21; http://dx.doi.org/10.2174/157341109787846171
  • Musiychuk K, Stephenson N, Bi H, Farrance CE, Orozovic G, Brodelius M, Brodelius P, Horsey A, Ugulava N, Shamloul AM, et al. A launch vector for the production of vaccine antigens in plants. Influenza Other Respir Viruses 2007; 1:19-25; PMID:19453476; http://dx.doi.org/10.1111/j.1750-2659.2006.00005.x
  • Buyel JF, Twyman RM, Fischer R. Extraction and downstream processing of plant-derived recombinant proteins. Biotechnol Adv 2015; 33(6 Pt 1):902-13; PMID:25922318; http://dx.doi.org/10.1016/j.biotechadv.2015.04.010
  • Hong M, Lee PS, Hoffman RM, Zhu X, Krause JC, Laursen NS, Yoon SI, Song L, Tussey L, Crowe JE Jr, et al. Antibody recognition of the pandemic H1N1 Influenza virus hemagglutinin receptor binding site. J Virol 2013; 87:12471-80; PMID:24027321; http://dx.doi.org/10.1128/JVI.01388-13
  • Shoji Y, Chichester JA, Bi H, Musiychuk K, de la Rosa P, Goldschmidt L, Horsey A, Ugulava N, Palmer GA, Mett V, et al. Plant-expressed HA as a seasonal influenza vaccine candidate. Vaccine 2008; 26:2930-4; PMID:18440103; http://dx.doi.org/10.1016/j.vaccine.2008.03.045
  • Shoji Y, Farrance CE, Bi H, Shamloul M, Green B, Manceva S, Rhee A, Ugulava N, Roy G, Musiychuk K, et al. Immunogenicity of hemagglutinin from A/Bar-headed Goose/Qinghai/1A/05 and A/Anhui/1/05 strains of H5N1 influenza viruses produced in Nicotiana benthamiana plants. Vaccine 2009a; 27:3467-70; PMID:19200814; http://dx.doi.org/10.1016/j.vaccine.2009.01.051
  • Mett V, Musiychuk K, Bi H, Farrance CE, Horsey A, Ugulava N, Shoji Y, de la Rosa P, Palmer GA, Rabindran S, et al. A plant-produced influenza subunit vaccine protects ferrets against virus challenge. Influenza Other Respir Viruses 2008; 2:33-40; PMID:19453491; http://dx.doi.org/10.1111/j.1750-2659.2008.00037.x
  • Shoji Y, Bi H, Musiychuk K, Rhee A, Horsey A, Roy G, Green B, Shamloul M, Farrance CE, Taggart B, et al. Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza. Vaccine 2009b; 27:1087-92; PMID:19100806; http://dx.doi.org/10.1016/j.vaccine.2008.11.108
  • Suzuki Y, Nei M. Origin and Evolution of Influenza Virus Hemagglutinin Genes. Mol Biol Evol 2002; 19:501-9; PMID:11919291; http://dx.doi.org/10.1093/oxfordjournals.molbev.a004105
  • Wiley DC, Skehel JJ. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Ann Rev Biochem 1987; 56:365-94; PMID:3304138; http://dx.doi.org/10.1146/annurev.bi.56.070187.002053
  • Chiu FF, Venkatesan N, Wua CR, Chou AH, Chen HW, Lian SP, Liu SJ, Huang CC, Lian WC, Chong P, et al. Immunological study of HA1 domain of hemagglutinin of influenza H5N1 virus. Biochem Biophys Res Commun 2009; 383:27-31; PMID:19324009; http://dx.doi.org/10.1016/j.bbrc.2009.03.106
  • Khurana S, Verma S, Verma N, Crevar CJ, Carter DM, Manischewitz J, King LR, Ross TM, Golding H. Bacterial HA1 vaccine against pandemic H5N1 influenza virus: Evidence of oligomerization, hemagglutination, and cross-protective immunity in ferrets. J Virol 2011a; 85:1246-56; PMID:21084473; http://dx.doi.org/10.1128/JVI.02107-10
  • Spitsin S, Andrianov V, Pogrebnyak N, Smirnov Y, Borisjuk N, Portocarrero C, Veguilla V, Koprowski H, Golovkin M. Immunological assessment of plant derived avian flu H5/HA1 variants. Vaccine 2009; 27:1289-92; PMID:19162113; http://dx.doi.org/10.1016/j.vaccine.2008.12.050
  • Bendandi M, Marillonnet S, Kandzia R, Thieme F, Nickstadt A, Herz S, Frode R, Inoges S, Lopez-Diaz de Cerio A, Soria E. et al. Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma. Ann Oncol 2010; 21:2420-7; PMID:20494963; http://dx.doi.org/10.1093/annonc/mdq256
  • Lai H, Engle M, Fuchs A, Keller T, Johnson S, Gorlatov S, Diamond MS, Chen Q. Monoclonal antibody produced in plants efficient treats West Nile virus infection in mice. PNAS USA 2010; 107:2419-24; PMID:20133644; http://dx.doi.org/10.1073/pnas.0914503107
  • Wilken LR, Nikolov ZL. Recovery and purification of plant-made recombinant proteins. Biotechnol Adv 2012; 30:419-33; PMID:21843625; http://dx.doi.org/10.1016/j.biotechadv.2011.07.020
  • Holler CJ. Purification of an acidic recombinant protein from transgenic tobacco (master thesis). Master Thesis, Virginia Polytechnic Institute and State University, Blacksburg, VA; 2007
  • Drossard J. Downstream processing of plant-derived recombinant therapeutic proteins. In Fischer R, Schillberg S (Eds.), Molecular farming: Plant-made pharmaceuticals and technical proteins. 2004. Wiley-VCH Verlag GmbH & Co., Germany
  • Valdes R, Gomez L, Padilla S, Brito J, Reyes B, Alvarez T, Mendoza O, Herrera O, Ferro W, Pujol M, et al. Large-scale purification of an antibody directed against hepatitis B surface antigen from transgenic tobacco plants. Biochem Biophys Res Commun 2003; 308:94-100; PMID:12890485; http://dx.doi.org/10.1016/S0006-291X(03)01335-4
  • Yongkiettrakul S, Boonyapakron K, Jongkaewwattana A, Wanitchang A, Leartsakulpanich U, Chitnumsub P, Eurwilaichitr L, Yuthavong Y. Avian influenza A/H5N1 neuraminidase expressed in yeast with a functional head domain. J Virol Methods 2009; 156:44-51; PMID:19038288; http://dx.doi.org/10.1016/j.jviromet.2008.10.025
  • Pagny S, Cabanes-Macheteau M, Gillikin JW, Leborgne-Castel N, Lerouge P, Boston RS, Faye L, Gomord V. Protein recycling from the Golgi apparatus to the endoplasmic reticulum in plants and its minor contribution to calreticulin retention. Plant Cell 2000; 12:739-56; PMID:10810147; http://dx.doi.org/10.1105/tpc.12.5.739
  • Tretter V, Altmann F, Marz L. Peptide-N4-(N-acetyl-β-glucosaminyl) asparagine amidase F cannot release glycans with fucose attached α 1→3 to the asparagine-linked N-acetylglucosamine residue. Eur J Biochem 1991; 299:647-52; http://dx.doi.org/10.1111/j.1432-1033.1991.tb16166.x

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.